These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11862363)
1. Light-enhanced startle: further pharmacological and behavioral characterization. Walker DL; Davis M Psychopharmacology (Berl); 2002 Jan; 159(3):304-10. PubMed ID: 11862363 [TBL] [Abstract][Full Text] [Related]
2. The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine. de Jongh R; Groenink L; van Der Gugten J; Olivier B Psychopharmacology (Berl); 2002 Jan; 159(2):176-80. PubMed ID: 11862346 [TBL] [Abstract][Full Text] [Related]
3. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress. Adamec R; Strasser K; Blundell J; Burton P; McKay DW Behav Brain Res; 2006 Feb; 167(2):270-86. PubMed ID: 16256211 [TBL] [Abstract][Full Text] [Related]
4. Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress. Adamec R; Muir C; Grimes M; Pearcey K Behav Brain Res; 2007 May; 179(2):192-207. PubMed ID: 17335916 [TBL] [Abstract][Full Text] [Related]
5. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Walker DL; Davis M Biol Psychiatry; 1997 Sep; 42(6):461-71. PubMed ID: 9285082 [TBL] [Abstract][Full Text] [Related]
6. Effects of buspirone and alprazolam treatment on the startle-potentiated startle response. Commissaris RL; Fomum EA; Leavell BJ Depress Anxiety; 2004; 19(3):146-51. PubMed ID: 15129416 [TBL] [Abstract][Full Text] [Related]
7. High illumination levels potentiate the acoustic startle response in preweanling rats. Weber M; Watts N; Richardson R Behav Neurosci; 2003 Dec; 117(6):1458-62. PubMed ID: 14674865 [TBL] [Abstract][Full Text] [Related]
8. Benzodiazepines have no effect on fear-potentiated startle in humans. Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826 [TBL] [Abstract][Full Text] [Related]
9. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats. Schweimer J; Fendt M; Schnitzler HU Eur J Pharmacol; 2005 Jan; 507(1-3):117-24. PubMed ID: 15659301 [TBL] [Abstract][Full Text] [Related]
10. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Walker DL; Davis M Psychopharmacology (Berl); 2002 Nov; 164(3):318-28. PubMed ID: 12424556 [TBL] [Abstract][Full Text] [Related]
11. Role of NMDA receptors in the syndrome of behavioral changes produced by predator stress. Blundell J; Adamec R; Burton P Physiol Behav; 2005 Sep; 86(1-2):233-43. PubMed ID: 16102786 [TBL] [Abstract][Full Text] [Related]
12. Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. Winslow JT; Noble PL; Davis M Biol Psychiatry; 2007 Feb; 61(3):389-95. PubMed ID: 16730332 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats. Adamec R; Creamer K; Bartoszyk GD; Burton P Eur J Pharmacol; 2004 Nov; 504(1-2):79-96. PubMed ID: 15507224 [TBL] [Abstract][Full Text] [Related]
14. Fear-potentiated startle, but not light-enhanced startle, is enhanced by anxiogenic drugs. Bijlsma EY; de Jongh R; Olivier B; Groenink L Pharmacol Biochem Behav; 2010 Jul; 96(1):24-31. PubMed ID: 20394767 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study. Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094 [TBL] [Abstract][Full Text] [Related]
16. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat. Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212 [TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306 [TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321 [TBL] [Abstract][Full Text] [Related]
19. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle. de Jongh R; Geyer MA; Olivier B; Groenink L Behav Brain Res; 2005 Jun; 161(2):190-6. PubMed ID: 15878207 [TBL] [Abstract][Full Text] [Related]
20. Temporary inactivation of the rostral perirhinal cortex induces an anxiolytic-like effect on the elevated plus-maze and on the yohimbine-enhanced startle response. Schulz-Klaus B; Fendt M; Schnitzler HU Behav Brain Res; 2005 Sep; 163(2):168-73. PubMed ID: 16029901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]